Classical Hodgkin's lymphoma (CHL) presenting with exclusively pulmonary symptoms is very unusual. We report two cases of CHL with atypical clinical presentations mimicking pulmonary infections. The fi rst case represents a stage IV CHL with secondary lung involvement, and the second case demonstrates a very rare case of CHL with isolated lung involvement, also known as primary pulmonary Hodgkin's lymphoma. The second patient was initially misdiagnosed and treated with six months of antibiotics before the correct diagnosis was made by a lung biopsy. Both patients received chemotherapy; one patient achieved complete remission and the other achieved near-complete remission.
INTRODUCTION
Classical Hodgkin's lymphoma (CHL) is a lymphoid neoplasm composed of multinucleated Reed-Sternberg (RS) cells and mononucleated Hodgkin's cells. It has a bimodal age distribution with the first peak at 15-35 years of age and the other peak much later in life. CHL commonly presents with localized cervical and mediastinal lymphadenopathy. Most patients present with stage I or II disease, and with the present treatment, most achieve long-term survival. [1] We present two patients with atypical pulmonary presentations of CHL.
CASE REPORT

Case 1
A 27-year-old previously healthy male presented with nonproductive cough, night sweats, and a 15-pound unintentional weight loss over 7 months. Extensive infectious workup was negative. Imaging studies revealed extensive bilateral upper lobe consolidations with bilateral hilar lymphadenopathy [ Figure 1a ]. Bronchoscopy demonstrated extrinsic compression and edema of the bronchi in the bilateral upper lobes and two left-sided endobronchial nodules [ Figure 1b ]. Endobronchial brushing and transbronchial biopsy were obtained.
Endobronchial brushing cytology revealed rare, large atypical mononucleated and binucleated cells with prominent nucleoli suspicious for Hodgkin's and RS cells [ Figure 2a ]. Concurrent lung biopsy showed dense inflammatory infiltrate with rare large atypical cells morphologically similar to those seen on the endobronchial brushing [ Figure 2b ]. Immunohistochemical studies demonstrated that these atypical cells were negative for CD45 [ Figure 2c ], CD3, and anaplastic lymphoma kinase 1 (ALK-1). They were positive for CD30 [ Figure 2d This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
Case Report consistent with stage IV CHL. The patient had completed six cycles of chemotherapy with doxorubicin, vinblastine, dacarbazine, and etoposide (AVD-E) and achieved complete remission at 6 months after initial diagnosis.
Case 2
A 35-year-old healthy male presented with a 5-month history of dry cough, fevers, night sweats, and a 20-pound unintentional weight loss. He was previously treated with antibiotics at an outside hospital with no relief of symptoms. A chest CT highlighted dense consolidations of the left upper lobe and lingula with central cavitation and multiple small cavitary nodules in the left lower lobe. No significant mediastinal or hilar lymphadenopathy was noted. Acid-fast bacilli sputum smear was positive; however, confirmatory tests for mycobacterial infection were negative. All other infectious workup was negative. The patient was placed on anti-tuberculosis therapy but had no clinical improvement after 3 months of treatment. A bronchoscopy was performed which revealed no abnormality. He was placed on multiple antibiotic regimens for another 3 months and had no clinical or radiological improvement.
A second bronchoscopy with transbronchial biopsy was performed. The transbronchial biopsy showed scattered atypical cells with convoluted and smudgy nuclei in a background of prominent mixed inflammatory cells [ Figure 3b ]. By immunohistochemistry, these atypical cells were negative for CD45 [ Figure 3c ], CD3, CD4, CD7, CD15, CD20, ALK-1, AE1/AE3. They were strongly positive for CD30 [ Figure 3d ] and weakly positive for Pax5. EBV-ISH (EBER) was negative. The findings were consistent with CHL.
A staging bone marrow was negative for lymphoma involvement. PET-CT highlighted innumerable hypermetabolic cavitary pulmonary masses and mildly hypermetabolic hilar lymph nodes [ Figure 3a ]. The overall pattern of disease distribution was consistent with primary pulmonary Hodgkin's lymphoma (PPHL). The patient underwent four cycles of AVD-brentuximab, vedotin chemotherapy, and follow-up imaging at 8 months posttreatment revealed near-complete resolution of the pulmonary masses.
DISCUSSION
Pulmonary involvement by CHL is commonly seen during the disease. It occurs as a secondary involvement through lymphangitic extension from adjacent lymph nodes or through hematologic spread. Lung involvement by CHL typically presents as multiple nodules or masses on imaging studies. [2] Cavitation and "pneumonia-like" consolidation patterns are rare. [2] [3] [4] Both of our patients presented with symptoms and radiographic findings highly concerning for pulmonary infections. In the second case, patient was placed on prolonged antibiotic treatment despite negative microbiologic workup. The lack of considering CHL in the differential diagnosis resulted in a significant delay in obtaining tissue biopsy for a definitive diagnosis. CHL with predominant lung involvement, also known as PPHL, is extremely rare with less than 100 reported cases. [5] [6] [7] [8] [9] [10] The disease is thought to arise from intraparenchymal lymphoid follicles or peribronchial lymph nodes. The largest case series reviewed by Radin included 61 cases of PPHL published between 1972 and 1986. The author observed that there was a slight female predilection with a bimodal distribution similar to nodal CHL. Common presenting symptoms were cough and dyspnea. The disease typically involves the upper lobes as single or multiple nodules, with nodular sclerosis PPHL as the most common histologic subtype. [9] The gold standard for diagnosis of CHL requires the identification of RS cells and Hodgkin's cells on tissue biopsy. Diagnosis of CHL by cytology has always been challenging due to the scant quantity of diagnostic RS or Hodgkin's cells. In addition, these lesional cells may be overlooked in a dense inflammatory background or misinterpreted as reactive pneumocytes or other neoplastic entities. Therefore, in young patients presenting with atypical pulmonary symptoms and imaging findings, a cytologic sample containing a mixed inflammatory background, especially with abundant eosinophils, should prompt the pathologist to thoroughly search for RS or Hodgkin's cells.
CONCLUSION
CHL is a relatively common lymphoma with high remission rate. Our cases demonstrate rare pulmonary presentation of CHL in young patients and the importance of considering it in the differential diagnosis to ensure timely diagnosis and treatment.
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